title: Comparison of proposed alternative methods for rescaling dialysis dose: resting energy expenditure, high metabolic rate organ mass, liver size, and body surface area.
abstract: A number of denominators for scaling the dose of dialysis have been proposed as alternatives to the urea distribution volume (V). These include resting energy expenditure (REE), mass of high metabolic rate organs (HMRO), visceral mass, and body surface area. Metabolic rate is an unlikely denominator as it varies enormously among humans with different levels of activity and correlates poorly with the glomerular filtration rate. Similarly, scaling based on HMRO may not be optimal, as many organs with high metabolic rates such as spleen, brain, and heart are unlikely to generate unusually large amounts of uremic toxins. Visceral mass, in particular the liver and gut, has potential merit as a denominator for scaling; liver size is related to protein intake and the liver, along with the gut, is known to be responsible for the generation of suspected uremic toxins. Surface area is time-honored as a scaling method for glomerular filtration rate and scales similarly to liver size. How currently recommended dialysis doses might be affected by these alternative rescaling methods was modeled by applying anthropometric equations to a large group of dialysis patients who participated in the HEMO study. The data suggested that rescaling to REE would not be much different from scaling to V. Scaling to HMRO mass would mandate substantially higher dialysis doses for smaller patients of either gender. Rescaling to liver mass would require substantially more dialysis for women compared with men at all levels of body size. Rescaling to body surface area would require more dialysis for smaller patients of either gender and also more dialysis for women of any size. Of these proposed alternative rescaling measures, body surface area may be the best, because it reflects gender-based scaling of liver size and thereby the rate of generation of uremic toxins.
authors.forename: John T
authors.initials: JT
authors.lastname: Daugirdas
authors.forename: Nathan W
authors.initials: NW
authors.lastname: Levin
authors.forename: Peter
authors.initials: P
authors.lastname: Kotanko
authors.forename: Thomas A
authors.initials: TA
authors.lastname: Depner
authors.forename: Martin K
authors.initials: MK
authors.lastname: Kuhlmann
authors.forename: Glenn M
authors.initials: GM
authors.lastname: Chertow
authors.forename: Michael V
authors.initials: MV
authors.lastname: Rocco
mesh_terms: D001830:Body Surface Area; D004734:Energy Metabolism / Q000502:physiology; D005260:Female; D006801:Humans; D007674:Kidney Diseases / Q000378:metabolism* / Q000473:pathology* / Q000628:therapy; D007677:Kidney Function Tests; D008099:Liver / Q000473:pathology; D008297:Male; D009929:Organ Size; D006435:Renal Dialysis; D012737:Sex Factors